Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 27 Feb 2025 – 20 Aug 2026, limited by SBI Nifty IT Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI Nifty IT Index Fund | Nifty 500 |
|---|---|---|
| 27 Feb 2025 | ₹100.00 | ₹100.00 |
| 13 Apr 2025 | ₹84.03 | ₹102.15 |
| 28 May 2025 | ₹96.26 | ₹112.13 |
| 12 Jul 2025 | ₹97.31 | ₹114.61 |
| 26 Aug 2025 | ₹93.38 | ₹112.07 |
| 10 Oct 2025 | ₹92.17 | ₹114.88 |
| 24 Nov 2025 | ₹96.57 | ₹116.53 |
| 07 Jan 2026 | ₹100.83 | ₹118.22 |
| 21 Feb 2026 | ₹83.79 | ₹115.16 |
| 07 Apr 2026 | ₹82.21 | ₹104.83 |
| 22 May 2026 | ₹75.81 | ₹111.50 |
| 06 Jul 2026 | ₹71.76 | ₹115.35 |
| 20 Aug 2026 | ₹80.85 | ₹115.74 |
| Metric | SBI · Direct · IDCW NAV ₹7.77 Very High risk ★☆☆☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| -12.52% | +5.06% | |
| — | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| -13.42% | +7.54% | |
| -11.09% | — | |
| — | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 24.36% | 13.54% | |
| -0.78 | 0.16 | |
| -1.06 | 0.22 | |
| -34.11% | -15.77% | |
| Nifty 500 | — | |
| — | +0.53% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 98.0% | |
| 0.54% | 0.34% | |
| ₹88.75Cr | ₹191.88Cr | |
| 0.25% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 31% | 38% | |
| Harsh Sethi | — | |
| 27 Feb 2025 | — | |
| 10 | — | |
| 100.1% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.